Advantage India in pharma sector: E&Y

By agencies   |   Tuesday, 24 May 2005, 07:00 Hrs
Printer Print Email Email
MUMBAI:Indian pharma companies hold a competitive advantage in the new product patent regime, says the new report titled 'Progressions 2005' released by Ernst & Young (E&Y).

According to Utkarsh Palnitkar, Health Sciences Industry Practice Leader, E&Y India, ''Any discussion on the global pharmaceutical supply chain can now no longer ignore India's relevance.

India is now becoming an integral part of the pharma value chain, as large global pharma companies continue to increase their sourcing of active pharmaceutical ingredients (APIs), off shoring of clinical development and partnering with domestic companies for new product development and marketing in India.

Over the long term, India is bound to have a larger impact on global pharma's Tax, Regulatory and IT environment beyond the obvious impact on its innovation and manufacturing.''

The report also observes that global pharma companies are taking unprecedented actions to regain public trust by engaging in an open dialogue around drug safety and drug promotional objectives while renewing their focus on demonstrating values through medicines.

SPOTLIGHT
GST rate cut to spur Bengaluru
The realty market in India's tech hub is set to grow as lower Goods and Services Tax (GST) rate..
SpiceJet plans aggressive
Budget passenger carrier SpiceJet plans to aggressively expand its international networks to fl..
Fossil Group sells smartwatch
Global watch and accessories maker Fossil Group has announced to sell its smartphone technolog..
Ola raises Rs 400 cr for electric
Leading ride-hailing cab aggregator Ola on Friday said it raised Rs 400 crore from its early in..